Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Pilot Study: Intensive Education in a Residential Camp Setting for Families of Young Children With Type 1 Diabetes (TotCamp)

21 juni 2017 uppdaterad av: University of Texas Southwestern Medical Center
18 preschool aged children and their families will attend structured, multidisciplinary, family-centered intensive education sessions over a 3-day weekend in a residential camp setting to address the unique challenges of managing type 1 diabetes mellitus in young children. A second 'booster' session, will be conducted 6 months later.

Studieöversikt

Status

Avslutad

Betingelser

Intervention / Behandling

Detaljerad beskrivning

We propose to deliver a structured multidisciplinary family-centered intervention over a 3-day weekend, with a second similar "booster" session 6 months later. The intervention will be based at our regional diabetes camp, Camp Sweeney. The proposed camp encounters aim to provide:

  • An opportunity for intensive education beyond that achievable in a single class, and without the unfavorable impacts of multiple weekday classes on family and work time.
  • Varied educational modalities including didactic sessions, practical demonstrations and role playing.
  • Close observation of each child throughout the day and night by experienced diabetes counselors and medical staff to identify and help correct maladaptive family behaviors.
  • A safe environment where parents can participate in group therapy sessions without child care worries.
  • An opportunity for age-appropriate child-centered educational and therapeutic activities.
  • An opportunity for families to form mutually-supportive friendships.
  • Fun weekends away where the parents have help caring for their diabetic children.

We will conduct this pilot study, which will enroll 18 preschool children age 3-5.5 years, with the goal of obtaining preliminary results for 15 subjects.

The primary outcome, to be determined approximately one month before and after each of the two camp sessions, is improvement in Hemoglobin A1c (HbA1c). This outcome will be compared with that of historical controls.

Exploratory Hypotheses:

Compared with pretreatment baseline and historical controls, subjects attending two 3-day sessions at a family diabetes camp will improve:

  • HbA1c 3 months after the first camp session
  • Hypoglycemia frequency, as measured by continuous glucose monitoring
  • Medical system utilization, as measured by telephone call frequency and also by emergency room visits and hospitalizations
  • Behavioral/QoL assessments, including the parents of young children version of the hypoglycemia fear survey (HFS-P-YC), the Behavioral Pediatrics Feeding Assessment Scale (BPFAS), and the general and diabetes modules of the PedsQL.
  • Diabetes knowledge, assessed by questionnaire
  • Development of friendships between subject families, assessed by questionnaire

Studietyp

Interventionell

Inskrivning (Faktisk)

18

Fas

  • Inte tillämpbar

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

2 år till 5 år (Barn)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Age 3-5.5 years old (+/- 2 months) at the date of first camp session they are eligible to join.
  • Child and Parents fluent in either English or Spanish.
  • Type 1 diabetes mellitus diagnosed for at least 10 months previous to date of first camp they are eligible to join.
  • Taking insulin
  • Custodial parent or guardian (preferable both parents or guardians) willing to attend both session of camp and the activities scheduled for them.
  • Parent or guardian must sign consent before any study procedures are performed.

Exclusion Criteria:

  • Neonatal diabetes (diagnosis in the first 3 months of life) or documented MODY; i.e., a likely genetic form of diabetes rather than an autoimmune etiology.
  • Post-surgical diabetes (e.g., pancreatectomy for congenital hyperinsulinism). Such patients often cannot secrete glucagon, leading to a particularly severe inability to defend against hypoglycemia.
  • Other severe chronic disease (e.g., cancer, cystic fibrosis) which in the judgment of the investigator is likely to significantly affect glycemic control.
  • Patients cannot be taking systemic corticosteroids at enrollment because of adverse effects on glycemic control, but we will not disqualify subjects who require such therapy during the study. Inhaled or topical corticosteroids are permissible.
  • Patients with hypothyroidism or hyperthyroidism must be clinically euthyroid and have free T4 and TSH within age-appropriate reference ranges at last medically indicated testing. Patients with out of range values may be retested after medication dose adjustment.
  • Developmental delay or behavioral disorder in the patient of sufficient severity, in the judgment of the investigator, to interfere with group activities.
  • Medical or psychiatric disorder in a parent of sufficient severity, in the judgment of the investigator, to interfere with group activities.
  • Celiac disease is not an exclusion criterion.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Övrig: Intensive Education
Attendance of 2 intensive education sessions
Beteende: Intensive Education
Participants will attend a 3 day family-centered, multidisciplinary, intensive education session at our regional diabetes camp, Camp Sweeney. A second 'booster' session will be conducted 6 months later.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in Hemoglobin A1c one month pre-camp to one month post-camp Session 1
Tidsram: One month pre-camp, one month post-camp
As compared to historical controls
One month pre-camp, one month post-camp
Change in Hemoglobin A1c one month pre-camp to one month post-camp Session 2
Tidsram: One month pre-camp, one month post-camp
As compared to historical controls
One month pre-camp, one month post-camp

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in Hypoglycemia frequency one month pre-camp to one month post-camp Session 1
Tidsram: One month pre-camp, one month post-camp
As measured by continuous glucose monitoring, and quantitated as area under the curve for blood glucoses <70 mg/dL.
One month pre-camp, one month post-camp
Change in Hypoglycemia frequency one month pre-camp to one month post-camp Session 2
Tidsram: One month pre-camp, one month post-camp
As measured by continuous glucose monitoring, and quantitated as area under the curve for blood glucoses <70 mg/dL.
One month pre-camp, one month post-camp
Medical system utilization ( emergency room visits, hospitalizations related to T1DM)
Tidsram: Duration of participation in study, expected to be 10 months
Composite measure. As compared to historical controls.
Duration of participation in study, expected to be 10 months
Change in PedsQL Family Impact Module one month pre-camp to one month post-camp Session 1
Tidsram: One month pre-camp, one month post-camp
Parent report
One month pre-camp, one month post-camp
Change in PedsQL Family Impact Module one month pre-camp to one month post-camp Session 2
Tidsram: One month pre-camp, one month post-camp
Parent report
One month pre-camp, one month post-camp
Change in PedsQL Pediatric Quality of Life Inventory one month pre-camp to one month post-camp Session 1
Tidsram: One month pre-camp, one month post-camp
Parent report for Toddlers, Parent report for Young Children, Young Child Report
One month pre-camp, one month post-camp
Change in PedsQL Pediatric Quality of Life Inventory one month pre-camp to one month post-camp Session 2
Tidsram: One month pre-camp, one month post-camp
Parent report for Toddlers, Parent report for Young Children, Young Child Report
One month pre-camp, one month post-camp
Change in PedsQL Diabetes Module one month pre-camp to one month post-camp Session 1
Tidsram: One month pre-camp, one month post-camp
Parent report for Toddlers, Parent report for Young Children, Young Child Report
One month pre-camp, one month post-camp
Change in PedsQL Diabetes Module one month pre-camp to one month post-camp Session 2
Tidsram: One month pre-camp, one month post-camp
Parent report for Toddlers, Parent report for Young Children, Young Child Report
One month pre-camp, one month post-camp
Change in Hypoglycemia Fear Survey one month pre-camp to one month post-camp Session 1
Tidsram: One month pre-camp, one month post-camp
Parents of young children version
One month pre-camp, one month post-camp
Change in Hypoglycemia Fear Survey one month pre-camp to one month post-camp Session 2
Tidsram: One month pre-camp, one month post-camp
Parents of young children version
One month pre-camp, one month post-camp
Change in Behavioral Pediatrics Feeding Assessment one month pre-camp to one month post-camp Session 1
Tidsram: One month pre-camp, one month post-camp
Behavior section
One month pre-camp, one month post-camp
Change in Behavioral Pediatrics Feeding Assessment one month pre-camp to one month post-camp Session 2
Tidsram: One month pre-camp, one month post-camp
Behavior section
One month pre-camp, one month post-camp

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

University of Texas Southwestern Medical Center

Utredare

  • Huvudutredare: Perrin White, MD, UT Southwestern Medical Center

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 juli 2014

Primärt slutförande (Faktisk)

1 augusti 2016

Avslutad studie (Faktisk)

1 januari 2017

Studieregistreringsdatum

Först inskickad

10 mars 2015

Först inskickad som uppfyllde QC-kriterierna

28 april 2015

Första postat (Uppskatta)

4 maj 2015

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

23 juni 2017

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

21 juni 2017

Senast verifierad

1 juni 2017

Mer information

Termer relaterade till denna studie

Nyckelord

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • STU 042014-061

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Typ 1-diabetes mellitus

Kliniska prövningar på Intensive Education

Sök liknande försök

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

CROs by country

CROs in Luxembourg

Betingelser

Sällsynta sjukdomar

Läkemedelsinterventioner

Kosttillskott

Sponsor / medarbetare

Platser

3
Prenumerera